The Group reported revenue of MNOK 10,065 in Q2 2025, compared with MNOK 9,878
in Q2 2024.   

Adjusted EBITDA in Q2 2025 was MNOK 1,311, down from MNOK 3,057 in Q2 2024. Br.
Birkeland AS sold its shares in the two pelagic fishing companies Br. Birkeland
Fiskebåtrederi AS and Talbor AS in Q2 2024.  Adjusted for gain from sale of
shares in these companies, the adjusted EBITDA was MNOK 1,792 in Q2 2024. The
decrease in earnings in Q2 2025 compared to Q2 2024 originates from the salmon
operation and the pelagic operation in Peru. Despite higher slaughtered volume
salmon and trout in the quarter the falling prices for salmon and trout gave a
significantly reduction in earnings from this operation compared to same quarter
in 2024. In Peru the substantial decrease in earnings in Q2 2025 compared with
Q2 2024 can be attributed to higher cost combined with declining prices for
fishmeal and fish oil during H1 2025.  

Adjusted EBIT in Q2 2025 was MNOK 767, compared to MNOK 2,555 in Q2 2024.
Adjusted for gain from sale of shares the adjusted EBIT was MNOK 1,290 in Q2
2024.   

Norskott Havbruk AS (Scottish Sea Farms Ltd) and Pelagia are the Group's two
largest joint ventures. Income from associates before fair value adjustment
related to biological assets totalled negative MNOK 46 in Q2 2025 (Q2 2024:
positive MNOK 131). The equivalent figure, including fair value adjustment of
biological assets, was negative MNOK 13 (Q2 2024: positive MNOK 142). Norskott
Havbruk AS had a significant y-o-y decrease in price realisation impacting
profitability in Q2 2025 compared to Q2 2024. Decrease in prices, especially for
marine oils, put pressure on the margins impacting profitability for Pelagia
Holding AS in Q2 2025 compared to Q2 2024. The Group's joint ventures and
associates have generated good results over time, are prominent enterprises in
their respective segments, and represent considerable value for Austevoll
Seafood ASA. Please refer to note 5 for further information on associates. 

Adjusted EBIT, including revenue from associates, was MNOK 754 in Q2 2025,
against MNOK 2,697 in the same period of last year. 

Operating profit (EBIT) after fair value adjustment of biological assets and
other income and expenses in Q2 2025 was MNOK 128 (Q2 2024: MNOK 2,854).  Fair
value adjustment related to biological assets in the quarter was negative at
MNOK 513, compared with a positive figure of MNOK 178 in Q2 2024.  

The Group's net interest expense in Q2 2025 was negative at MNOK 155 (Q2 2024:
negative at MNOK 175). Net other financial expenses in the quarter totalled MNOK
42. The equivalent figure in Q2 2024 was negative at MNOK 34. 

The result before tax for Q2 2025 was MNOK 14, affected by a substantial
negative biomass adjustment and low prices for salmon and trout (Q2 2024: MNOK
2,645).  

The uncertainty surrounding tax estimates is considerably greater than usual due
to the authorities imposing a resource rent tax on Norwegian aquaculture in May
2023, followed by the creation of a norm-price council. This has resulted in a
significant time lag before companies have clarity on the authorities' specified
realised prices for the period. 

The result after tax in Q2 2025 was MNOK 106, compared with MNOK 2,172 in Q2
2024. 

For further information please see attached report and presentation.

Questions and comments may be addressed to the company's CEO, Arne Møgster, or
to CFO, Britt Kathrine Drivenes.

This information is subject of the disclosure requirements acc. to Section 5-12
vphl (Norwegian Securities Trading Act).